What are Cannabis Based Medical Products
What is Medical Cannabis? What is it treated for? Cannabis Based Medical Products (CBMPs) or Medical Cannabis are medications derived from the cannabis plant, containing cannabidiol (CBD) and/or Tetrahydrocannabinol (THC – which is the psychoactive substance in cannabis). In the UK medical cannabis has been legal since 2018 for the treatment of psychological, neurological, and chronic pain conditions as well as, palliative and/or end of life care: for sake of brevity a full list of conditions treated in the UK is highlighted in eligibility section of this website. What’s the eligibility criteria? With cannabis based medical products (CBMPs) being unlicenced, the census would be for patients to evidence unmet clinical needs i.e., their health is not improving despite having ongoing treatment or interventions via conventional healthcare services. It is important for all patients to recognise that due to cannabis containing a psychoactive substance, for the safety of potential patients, if you have any of the diagnosis listed in the exclusion criteria, you will not be eligible. We would advise these patients to liaise with their consultants at the NHS and explore an alternative treatment method to support their health needs. Patients have a right to a second opinion, provided they do not have any counterindications listed in the exclusion criteria below. Patient’s must be over 18 years of age. Exclusion Criteria? Like all medications, CBMPs is not advisable to use if you struggle from one of the following: - Suffer with high BP (If this is not stable) History of psychosis Diagnosis of schizophrenia Heart condition (Which has NOT been stable for 6+ months) Pregnant or breast-feeding What are the side effects of medical cannabis? Side effects of CBMPs include: Drowsiness Confusion Imbalance Euphoria Diarrhoea Dry mouth Anxiety and/or Depression Heart Palpitations Psychological Dependence Tolerance Cannabis hyperemesis syndrome (CHS) Adverse reactions include: Headaches Migraines ...
continue reading













